|
 |
RosiglitazoneThis page contains recent news articles, when available, and an overview of Rosiglitazone but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Rosiglitazone (when available) Rosiglitazone, a member of the drug group known as the thiazolidinediones or "insulin sensitizers", is not chemically or functionally related to the alpha-glucosidase inhibitors, the biguanides, or the sulfonylureas. Rosiglitazone targets insulin resistance and, hence, is used alone or with metformine or sulfonylurea to improve glycemic control in patients with type 2 diabetes mellitus. For the treatment of Type II diabetes mellitus Mechanism Of Action: Rosiglitazone acts as an agonist at peroxisome proliferator activated receptors (PPAR) in target tissues for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPAR-gamma receptors regulates the transcription of insulin-responsive genes involved in the control of glucose production, transport, and utilization. In this way, rosiglitazone enhances tissue sensitivity to insulin. News Articles on Rosiglitazone NATURALLY SAVVY: My Desert-Island Food of Choice? Spirulina (STORY 4 of 6 STORIES) - Jan 3, 2010 Rosiglitazone is an anti-diabetic drug that has been associated with increased risk of osteoporosis. But a study published in the US National Library of ... KFSM Egypt records one of the highest diabetes rates in the MENA region with 11 per ... - Dec 28, 2009 ..."Scientific researches all over the world have proved the effectiveness of Rosiglitazone (Avandia) in controlling the sugar levels for a long time, ... Zawya Anti-Diabetes Pill Balaglitazone on Track for Approval, Offers Less Weight ... - Jan 4, 2010 ...receptor)-gamma agonist, believed to have a better safety profile than full PPAR-gamma agonists like pioglitazone (Actos) and rosiglitazone (Avandia). ... DrugWatch.com Avandia Lawsuit Plaintiffs Ordered to Produce Basic Medical Records in MDL - Dec 30, 2009 Avandia (rosiglitazone) is a type 2 diabetes drug approved by the FDA in 1999. It is a thiazolidinedione agent, which acts by increasing the body's ... AboutLawsuits.com ORIGINAL RESEARCH COMMUNICATION - Dec 18, 2009 More specifically, these drugs (rosiglitazone, pioglitazone, and ciglitazone as well as the selective PPAR model INT131) increase the HMW/total adiponectin ... Am J Clin Nutr (subscription) Steven A Kliewer and David J Mangelsdorf - Dec 18, 2009 The thiazolidinedione drugs, which include rosiglitazone (Avandia; GlaxoSmithKline, London, United Kingdom) and pioglitazone (Actos; Takeda Pharmaceutical ... Am J Clin Nutr (subscription) New research finds physicians seek more novel diabetes drugs - Dec 17, 2009 ...which is not surprising given the cardiovascular safety concerns associated with GlaxoSmithKline's Avandia (rosiglitazone maleate) and the more recent ... Drug Store News (blog) Pharmaceutical industry financial performance - Dec 11, 2009 Safety-related revenue losses have also been rising in recent years (for example, for valdecoxib (Bextra; Pfizer), rosiglitazone (Avandia; GlaxoSmithKline), ... Nature.com (subscription) Significant reduction in HbA1c with Balaglitazone and improved safety profile - Jan 4, 2010 Balaglitazone is a novel partial agonist of PPAR-gamma, which elicits only 52% of the PPAR-gamma activation observed with both pio- and rosiglitazone. ... PipelineReview.com (press release) أكدت عدم صØØ© قائمة نشرتها الصØÙ? Øول أدوية ضارة بالصØØ© - Dec 14, 2009 المعروÙ? علميا (Rosiglitazone) وبالاسم التجارى (Ø£Ù?نديا Avandia) وعلاقته بالإصابة بجلطات القلب بنسبة Ù¤Ù %ØŒ أو دواء معروÙ? علميا باسم (Pioglitazone) والاسم ... اتحاد الإذاعة و التلفزيون المصرى Variation in Event Rates in Trials of Patients With Type 2 Diabetes - Oct 20, 2009 Suppose, for illustration, that cardiovascular outcomes are ascertained with probabilities of 40% in the rosiglitazone group and 50% in the control group ... Journal of American Medical Association (subscription) Study Shows Negative Association Between the Use of Thiazolidinediones and the ... - Oct 22, 2009 MONTREAL -- October 22, 2009 -- The ability of thiazolidinediones such as metformin and rosiglitazone to lower blood sugar levels in type 2 ... DG News New DPP4 inhibitor launched - Nov 12, 2009 In 370 patients with inadequate glycaemic control on pioglitazone or rosiglitazone alone, add-on therapy with saxagliptin 5mg daily produced a greater mean ... Healthcare Republic Confusing Choices for Doctors and Type 2 Diabetes Patients - Oct 23, 2009 GlaxoSmithKline's Avandia (rosiglitazone), a thiazolidinedione, carries a black box warning from the FDA due to its association with an increased frequency ... Genetic Engineering News (press release) 매ì?¼ê²½ì œ 홈 > 뉴스센터 > êµì œ - Oct 22, 2009 Furthermore, total cholesterol and low density lipoproteins were significantly reduced with liraglutide treatment compared to rosiglitazone, glimepiride or ... 매일경제 Adverse Events in Randomized Trials Neglected, Restricted, Distorted, and Silenced - Oct 26, 2009 Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone. Am Heart J. 2008;156(1):23-30. ... Archives of Internal Medicine US FDA slammed over post-marketing studies - Oct 28, 2009 ...likeâ€? Schering-Plough/Merck & Co's cholesterol-lowerer Vytorin (ezetimibe and simvastatin) and GlaxoSmithKline's diabetes drug Avandia (rosiglitazone). ... Pharma Times New drug for type 2 diabetes - Oct 29, 2009 The safety and efficacy of saxagliptin as add-on therapy to metformin, thiazolidinediones (pioglitazone, rosiglitazone), or glyburide was evaluated in three ... Clinical Advisor BREAKING NEWS: Relenza helps GSK return to sales growth - Oct 28, 2009 The Avandia (rosiglitazone) diabetes franchise brought in £185 million, down 14%, while revenues from GSK's HIV franchise fell 7% to £392 million. ... Pharma Times Afirman que habrÃa una macabra historia detrás de Zulma Lobato - Nov 9, 2009 El hecho en cuestión es que Dekleve debÃa recetar un medicamento para una mujer que sufrÃa leucemia, y habrÃa recetado "Rosiglitazone", ... Nova 11월부터 헵세ë?¼-ë°”ë?¼í?¬ë£¨ë“œ êµ?체투여 ì?¸ì • - Oct 30, 2009 ...ê°œì •ì•ˆì?€ 헵세ë?¼ì •ê³¼ ë°”ë?¼í?¬ë£¨ë“œì • êµ?체투여 ì?¸ì •ì™¸ì—?ë?„ â–³Pioglitazone + Metformin ê²½êµ¬ì œ(품명: ì•¡í† ìŠ¤ ë©”íŠ¸ì • 15/850) â–³Rosiglitazone + Metformin ê²½êµ¬ì œ(품명: ... 메디포뉴스 Los tiazolidinediones tienen un lugar en ciertos pacientes especÃficos - Oct 27, 2009 2009) Montreal, QC — Aunque el estudio Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD), y otros han detectado ... theheart.org 'Link' met kanker leidt tot onrust - Oct 28, 2009 Hetzelfde zou gelden voor het middel rosiglitazone van GlaxoSmithKline en pioglitazone van Takeda. Die drie medicijnen, allemaal pillen, maken mensen ... De Standaard 헵세ë?¼ì •Â·ë°”ë?¼í?¬ë£¨ë“œì •, ë‘? ì•½ì œ êµ?체투여 ì?¸ì • - Oct 22, 2009 ...'Rosiglitazone + Glimepiride ê²½êµ¬ì œ(품명: ì•„ë§ˆë°˜ì • 등)'ë?„ Glimepiride 추가 투여 ì‹œ 급여가 ì?¸ì •ë?˜ë?„ë¡? 변경했다. í•ì•…ì„±ì¢…ì–‘ì œ 'GnRH ì£¼ì‚¬ì œ'는 í—ˆê°€ì‚¬í• ë²”ìœ„ë¥¼ ... 메디포뉴스 Victoza, le médicament anti-diabète fait perdre du poids - Oct 26, 2009 ...deux études en trithérapie comparant un traitement qui comprenait Victoza et de la metformine en association au glimépiride ou à la rosiglitazone (une ... Mondesante.com FDA Advisers Urge Risk Assessment When Prescribing Rosiglitazone ( … - Jul 31, 2007 Although sparing rosiglitazone by recommending that it be kept on the market, the advisers also confirmed the validity of a much-debated meta-analysis by ... MedPage Today Drug can help prevent diabetes, study says - Sep 16, 2006 The drug, rosiglitazone or Avandia, taken for three years, ... Rosiglitazone is not without risks. In the study, for every 1000 people who took 8 milligrams ... Boston Globe FDA Seizes Paxil, Avandamet Tablets - Mar 10, 2005 The FDA also says some Avandamet tablets did not have an accurate dose of rosiglitazone, an active ingredient in the drug. Avandamet is a combination of two ... FOXNews New Study Finds No Significant Heart Attack Risk From Diabetes Drug - Jun 5, 2007 The British researchers saw no increased risk for cardiac events among those taking Avandia (generic name rosiglitazone) and those not taking it. ... Washington Post Diabetes Drug Linked to Higher Risk of Death - Nov 24, 2008 In a surprise finding, however, patients taking rosiglitazone did not suffer ... Rosiglitazone has been the subject of considerable controversy since 2007, ... New York Times Drug 'could slash diabetes cases' - Sep 15, 2006 The Lancet study suggests giving a diabetes drug called rosiglitazone to people ... By the end of the study, 280 of the people on rosiglitazone developed ... BBC News Rosiglitazone Increases MI and CV Death? - May 21, 2007 May 21, 2007 (Cleveland, OH) - A new meta-analysis has suggested that the diabetes drug rosiglitazone (Avandia, GlaxoSmithKline) may increase the risk of MI ... Medscape Major changes to rosiglitazone indications - Aug 20, 2008 ...by Michael Woodhead. Patients taking rosiglitazone products Avandia or Avandamet are being told to see their doctor as soon as possible to review their ... 6minutes Diabetes Drug May Slow Eye Disease - Jun 10, 2008 At the start of the study, 14 eyes of the people in the rosiglitazone group (6.4 ... After three years, 19.2 percent of the rosiglitazone group and 47.4 ... Washington Post Debate renewed: diabetes drug ups heart risk.(This Week)(rosiglitazone... - Sep 15, 2007 The popular diabetes drug rosiglitazone, marketed as Avandia, ... Rosiglitazone initially came under scrutiny earlier this year when an analysis of ... Free with registration - Science News - AccessMyLibrary.com Does treatment with rosiglitazone reduce the incidence of diabetes in... - Oct 28, 2006 DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators et al. (2006) Effect of rosiglitazone on the frequency ... Nature.com Diabetes drugs 'pose heart risk' - Jul 27, 2007 More than 1.5 million prescriptions for rosiglitazone and pioglitazone were issued in ... Rosiglitazone, brand name Avandia, was linked to heart attacks by ... BBC News More evidence diabetes drug linked to fractures - Apr 29, 2008 Pioglitazone and rosiglitazone, also known by the trade names Actos and Avandia, ... They note that pioglitazone and rosiglitazone account for 21 percent of ... Reuters Alzheimer's theory set for drug test - May 1, 2006 ..."I don't think this is hype for rosiglitazone," adds Dr. Sam Gandy, director of the Farber Institute for Neurosciences at Philadelphia's Thomas Jefferson ... USA Today … Orders New Safety Labels for Rosiglitazone (Avandia) and Pioglitazo... - Jun 6, 2007 By Peggy Peck, Managing Editor, MedPage Today. WASHINGTON, June 6 -- FDA Commissioner Andrew C. von Eschenbach, MD, told a congressional hearing today that ... MedPage Today Rosiglitazone and Metformin ( Systemic). - Oct 27, 2005 Rosiglitazone and metformin ROS-e-glit-a-zone and met-FOR-min combination is used to treat high blood sugar levels that are caused by a type of diabetes ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Glaxo's Avandia fails to slow plaque progression - Nov 12, 2008 Noting the "substantial controversy regarding the use of rosiglitazone," Dr. Beatriz Rodriguez of the Pacific Health Research Institute in Honolulu said, ... Reuters Diabetes drugs to include heart failure warnings - Aug 15, 2007 ..."Health Canada's review of the safety data on rosiglitazone is ongoing, and is expected to be completed by late fall 2007," Alastair Sinclair, ... CTV.ca GlaxoSmithKline PLC - Avandia Positive ADOPT Result. - Dec 4, 2006 In ADOPT, rosiglitazone was reported to be generally well-tolerated among the large ... There was no significant difference between the rosiglitazone and ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Rosiglitazone (Avandia) Heart Attack Risk 'not Cause For Alarm', … - May 23, 2007 A study published in The New England Journal of Medicine suggests a link between taking rosiglitazone, used to treat Type 2 diabetes, and an increased risk ... Medical News Today - Medical News Today (press release) Spironolactone effectively counteracts rosiglitazone-associated... - Sep 1, 2005 SAN DIEGO -- Spironolactone appears to be the most effective antidiuretic for the management of rosiglitazone-associated fluid retention, Janaka Karalliedde ... Free with registration - Family Practice News - AccessMyLibrary.com Pharmacokinetics and pharmacodynamics of rosiglitazone in relation to... - Jul 5, 2006 1 Institute of Pharmacology of Natural Products & Clinical Pharmacology, University of Ulm, Ulm; Department of Pharmacology, Clinical Pharmacology Unit, ... Nature.com Drug regulator's warning on rosiglitazone to hit sales - Dec 8, 2008 New Delhi: A warning by India's drug regulator that anti-diabetic medication rosiglitazone poses a risk for heart patients will dampen sales of the drug, ... Livemint Diabetes drug Avandia raises bone loss_English_Xinhua - Dec 3, 2007 This study conducted in mice found that over the long term, Avandia (rosiglitazone) may speed osteoporosis, due to both increased bone resorption and ... æ–°å?Žç½‘ … Blood Flow & Metabolism - Abstract of article: Rosiglitazone and 15... - Feb 18, 2005 This work was supported by grants from the Spanish Ministries of Health FIS-PI030304 (MAM) and Science and Technology SAF2002-04487-C02-01 (IL), ... Nature.com GlaxoSmithKline to revise Avandia® (rosiglitazone maleate) label in … - Jan 26, 2008 GlaxoSmithKline (GSK) announced today that it will revise its European label for Avandia® (rosiglitazone maleate). The EMEA's Committee for Medicinal ... webwire.com Rosiglitazone Linked to New/Worsening Macular Edema - Jan 5, 2006 Jan. 5, 2006 — The US Food and Drug Administration (FDA) and GlaxoSmithKline have notified healthcare professionals via letter regarding very rare ... Medscape Rosiglitazone monotherapy for type 2 diabetes mellitus—too soon to … - Jan 25, 2007 Kahn SE et al. (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355: 2427–2443 PubMed ... Nature.com Rosiglitazone improves lipoatrophy, metformin improves other forms of... - Sep 12, 2005 Patients with lipodystrophy require individualised care, emphasise Dutch investigators writing in the September 6 th edition of the Annals of Internal ... Aidsmap Diabetes drug side effect reports triple - Jul 13, 2007 The reports involve rosiglitazone, sold as Avandia and Avandamet. Reporting a drug's side effects is voluntary, and only a crude indication rather than a ... USA Today Leaked NEJM Manuscript on Rosiglitazone (Avandia) Puts GSK Under … - Jan 30, 2008 By Peggy Peck, Executive Editor, MedPage Today. WASHINGTON, Jan. 30 -- Citing a bad case of poor judgment, an independent reviewer for the New England ... MedPage Today … Mid-Summer's Night DREAM: Diabetes Prevention (Part 1-Rosiglitazone... - Sep 19, 2006 In the rosiglitazone-treatment arm, investigators reported data on the 5269 ... Of these events, 11.6% individuals treated with rosiglitazone and 26.0% ... Diabetes In Control … type 2 diabetes patients: glimepiride, rosiglitazone look good.(New... - Jul 1, 2005 The data on rosiglitazone (GlaxoSmithKline's Avandia) were presented in a poster ... Both were titrated up as necessary-twice daily rosiglitazone to 4 mg or ... Free with registration - Pediatric News - AccessMyLibrary.com Is rosiglitazone associated with increased risk for cardiovascular... - Jul 6, 2007 Nissen SE and Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356: 2457–2471 ... Nature.com ADA: VA Diabetes Trial Appears to Vindicate Rosiglitazone (Avandia) … - Jun 8, 2008 By John Gever, Staff Writer, MedPage Today. SAN FRANCISCO, June 8 -- The last of three major studies of tight glucose control in type 2 diabetes reported at ... MedPage Today … And The Launch Of Avandamet(R) (Rosiglitazone Maleate And Metformin... - Jul 14, 2006 Avandamet is the only combination of a thiazolidinedione, rosiglitazone maleate (separately ... The combination of rosiglitazone and metformin provides two ... Medical News Today - Medical News Today (press release) Rosiglitazone (Systemic). - Jul 28, 2005 Rosiglitazone (ROS-e-glit-a-zone) is used to treat a certain type of diabetes mellitus (sugar diabetes) called type 2 diabetes. It may be used alone or with ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Does treatment with rosiglitazone increase cardiovascular risk of... - Jun 27, 2007 Nissen SE and Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356: 2457–2471 ... Nature.com 'Rosiglitazone' removed from diabetes drugs - Dec 11, 2008 CHENNAI: The debate over the use of controversial anti-diabetes drug 'rosiglitazone,' associated with heart attacks, congestive heart failure and bone ... The Hindu Rosiglitazone Plus Insulin For Type 1 Improves Glycemic Control, BP … - Jul 12, 2005 ..."Rosiglitazone in combination with insulin resulted in improved glycemic control and blood pressure without an increase in insulin requirements, ... Diabetes In Control Rosiglitazone reduces the incidence of new-onset diabetes.(News … - Nov 1, 2006 In a randomized, double-blind, placebo-controlled trial recently published in Lancet, the thiazolidinedione (or "glitazone") rosiglitazone statistically ... Free with registration - Formulary - AccessMyLibrary.com Does rosiglitazone adversely affect bone formation and bone mineral … - Apr 20, 2007 Grey A et al. (2007) The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy ... Nature.com FDA Approves Avandamet(R) (rosiglitazone Maleate And Metformin HCl) … - Jul 16, 2006 GlaxoSmithKline announced today FDA approval of Avandamet (R) (rosiglitazone maleate and metformin HCl) for use as initial treatment of type 2 diabetes as ... Medical News Today - Medical News Today (press release) Patients Taking Rosiglitazone Have Higher Risk of Death, Heart... - Nov 24, 2008 CHICAGO -- November 24, 2008 -- Older adults who take rosiglitazone appear to have a higher risk of death and heart failure than those taking pioglitazone, ... DG News … Therapy; Avandamet is combined metformin-rosiglitazone for type 2 ... - Jan 16, 2005 Metformin (a biguanide) and rosiglitazone (a thiazolidinedione) counter insulin ... "Recently, a single-tablet combination of metformin and rosiglitazone, ... Pay-Per-View - Heart Disease Weekly - Factiva, from Dow Jones Glaxo Diabetes Drug Raises Heart Risk; Takeda Lowers - Sep 12, 2007 The Glaxo medicine, also known as rosiglitazone, was the world's best-selling ... ``Whatever statistical study you use, you find that rosiglitazone still ... Bloomberg Diabetes drug 'increases risk of heart attack' - Dec 12, 2007 Avandia, also known as rosiglitazone, comes from a family of medicines known as thiazolidinediones (TZDs) which have previously been linked to heart ... Times Online FDA Reviews Cardiovascular Risk Data for Rosiglitazone - May 30, 2007 By News Staff. The FDA is investigating potential safety issues related to rosiglitazone maleate, which is used to treat type 2 diabetes, but has suggested ... AAFP News Now FDA Adds MI Warning to Rosiglitazone (Avandia) Black Box - Nov 14, 2007 By Peggy Peck, Executive Editor, MedPage Today. ROCKVILLE, Md. -- The FDA ordered today that a myocardial infarction warning be added to the black box ... MedPage Today … drug might hike heart risk.(BIOMEDICINE)(rosiglitazone or Avandia)(... - Jun 23, 2007 A popular prescription drug for type 2, or adult-onset, diabetes increases a person's risk of heart attack, an analysis of 42 clinical trials suggests. ... $4.95 - Science News - ECNext Diabetes drug holds promise, study shows - Oct 13, 2006 Pigeon is counting on a drug called rosiglitazone that researchers say can ... Health Canada hasn't approved the use of rosiglitazone for people at risk of ... Canada.com New oral drug for type 2 diabetes shows promise - Feb 15, 2007 Patients treated with rosiglitazone had a 1.3 percent decrease in HbA1c, ... Patients taking rosiglitazone experienced a significant average increase in ... Reuters Avandia heart risks seen at the population level - Dec 11, 2007 Further analysis revealed that the risks were largely confined to patients who were using Avandia, known generically as rosiglitazone. ... Reuters UK Rosiglitazone Crosses Placenta in First Trimester - May 3, 2005 Women who take rosiglitazone during pregnancy can expect some of the drug to reach the fetus during the first trimester, new research shows. ... Diabetes In Control Study explains diabetes drug bone fracture risk - Dec 2, 2007 Avandia, known generically as rosiglitazone, also has been linked to increased risk of heart attack. The US Food and Drug Administration said last month ... Reuters UK ADA: VA Trial Assertion on Rosiglitazone (Avandia) Heart Safety... - Jun 10, 2008 By John Gever, Staff Writer, MedPage Today. SAN FRANCISCO, June 12 -- The VA Diabetes Trial analysis that showed no extra cardiovascular risk from ... MedPage Today New Study Questions Avandia's Heart Risk - Aug 8, 2007 ..."We don't have sufficient data to adjudicate the association of rosiglitazone with increased cardiovascular risk," said lead researcher Dr. Sanjay Kaul, ... Washington Post … Decrease of Adipocyte Size after Rosiglitazone Treatment in High-... - Aug 13, 2006 Correspondence: Joseph R. Vasselli Obesity Research Center, St. Luke's-Roosevelt Hospital Center, 1111 Amsterdam Avenue, New York, NY 10025. ... Nature.com Rosiglitazone A Viable Option for Children - Nov 29, 2005 Children assigned rosiglitazone lowered A1c by .25% over those on metformin but had average weight gain of 3 kg vs. no weight gain among those assigned ... Diabetes In Control Class of diabetes drugs may up heart risk - Aug 29, 2008 Rosiglitazone and pioglitazone are the two major thiazolidinediones. "At this time, justification for use of thiazolidinediones is very weak to non-existent ... United Press International Anti-diabetes pills 'unjustified' - Apr 26, 2007 Trials show rosiglitazone pills do work, but so does weight loss, which is a safer ... And they said giving rosiglitazone to people with impaired glucose ... BBC News Avandia heart risks seen at the population level - Dec 12, 2007 Further analysis revealed that the risks were largely confined to patients who were using Avandia, known generically as rosiglitazone. ... Reuters India MI Risks Linked to Rosiglitazone - Sep 12, 2007 Recent reports and discussions examining potential cardiovascular adverse effects of the diabetes drug rosiglitazone have left many clinicians uncertain ... Journal of American Medical Association - Journal of American Medical Association... Diabetes Drug Boosts Chemo's Effectiveness - May 7, 2007 MONDAY, May 7 (HealthDay News) -- The diabetes drug rosiglitazone (brand name Avandia) dramatically increases the potency of platinum-based cancer drugs, ... Washington Post Diabetes drug tied to increased cancer prevalence - Jul 18, 2007 The use of Avandia (rosiglitazone) increased the malignancy risk by 89 percent, whereas the increased risk associated with Actos (pioglitazone) was not ... Reuters VA Is Limiting Use of Diabetes Drug - Oct 18, 2007 The VA decided to remove Avandia, known generically as rosiglitazone, from its formulary on Oct. 5, according to a statement yesterday. ... New York Times Diabetes Therapy; Rosiglitazone reduces proinsulin:insulin ratio in... - Mar 5, 2005 2005 MAR 5 - (NewsRx.com & NewsRx.net) -- Rosiglitazone, but not glyburide, reduces circulating proinsulin and the proinsulin:insulin ratio in type 2 ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones RECORD interim results tabulated in response to rosiglitazone meta- … - Jul 1, 2007 In direct response to results of the recent meta-analysis examining cardiovascular risk associated with rosiglitazone treatment, researchers of the ... Cardiology Today The Rosiglitazone Story — Lessons From an FDA Advisory Committee … - Sep 4, 2007 Thiazolidinediones (TZDs), such as rosiglitazone, are peroxisome proliferator-activated receptor-γ agonists that reverse or ameliorate many of the adverse ... Medscape … Has Cholesterol Advantages Versus Rosiglitazone in Elderly... - May 2, 2006 By Mike Fillon. CHICAGO, IL -- May 2, 2006 -- A new study shows that pioglitazone and rosiglitazone exert significantly different effects on lipid ... DG News … Association Strongly Advises Patients Using Rosiglitazone to See... - Jun 5, 2007 Although the findings from RECORD (Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes) found no significant increase in ... HealthNewsDigest.com Rosiglitazone Is Associated with Increased Cardiovascular Mortality - Mar 15, 2008 Background: Rosiglitazone (Avandia) is one of two thiazolidinedione agents available for managing glucose levels in patients with type 2 diabetes ... AAFP News Now Rosiglitazone to Stay on US Market With New Warnings About MI - Nov 20, 2007 The FDA has decided to allow the diabetes drug rosiglitazone (Avandia, GlaxoSmithKline) to stay on the market with increased warnings about the risk of ... Diabetes In Control Steven Nissen and Robert Califf: A Conversation About Rosiglitazone - Aug 21, 2007 The May 2007 online publication of the meta-analysis "Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death From Cardiovascular Causes," in ... Medscape … Agency Confirms Positive Benefit-Risk Balance For Rosiglitazone... - Oct 19, 2007 This raised concerns over the benefit-risk balance of both rosiglitazone and ... In addition, the combination of rosiglitazone and insulin should only be ... Medical News Today - Medical News Today (press release) Rosiglitazone analysis sparks safety controversy - May 22, 2007 A meta-analysis of studies of rosiglitazone, a drug used in the treatment of diabetes, suggests a significantly increased risk of myocardial infarction ... Aidsmap GSK response to Nature Medicine article on rosiglitazone and bone in ... - Dec 6, 2007 London, UK - The Nature Medicine study adds further context on the possible involvement of thiazolidinediones (TZDs) in osteoclast activity. ... webwire.com Review of Rosiglitazone for type 2 diabetes mellitus - Jul 18, 2007 Little evidence supports using rosiglitazone (Avandia) to improve the quality or length of life among adults with diabetes, according to a systematic review ... News-Medical.net Possible Rosiglitazone Risk for Women - Feb 22, 2007 The FDA and GlaxoSmithKline are advising health care professionals to consider fracture risk when treating female type 2 diabetes patients with ... Facts and Comparisons Diabetes drugs may cause blindness: Health Canada - Dec 21, 2005 The company says patients taking the tablets, which contain the ingredient rosiglitazone, should not stop taking the drugs, but should consult their eye ... Globe and Mail Novo Nordisk says Phase 3 study shows liraglutide cuts both glucose... - Sep 14, 2007 The study investigated the effect of different doses of liraglutide in combination with metformin and rosiglitazone, and included 533 patients with type 2 ... Forbes Rosiglitazone study bears more bad news - Jul 30, 2007 By Owen Dyer. "I know I've made life more difficult for many of you in the last few months," Dr Steven Nissen of the Cleveland Clinic told a meeting of the ... National Review of Medicine Rosiglitazone, Not Ramipril, Prevents Progression to Diabetes in... - Dec 14, 2006 Among patients at risk for progression to diabetes, metformin and acarbose therapy each modestly reduce the likelihood of progression; dietary modifications ... Medscape Diabetes drug raises heart safety concerns - Nov 9, 2007 Rosiglitazone should not be used as part of a "triple therapy" in combination ... Glaxo said patients taking rosiglitazone, especially those with underlying ... Pay-Per-View - The Record - ProQuest Archiver Body weight and infertility linked - Aug 24, 2007 ..."The rosiglitazone findings are of great significance for scientists researching egg maturation within the ovary. But at this stage, the research findings ... The Age Risk of Myocardial Infarction With Rosiglitazone Dependent on Dose... - May 8, 2008 By Chris Berrie. BERLIN -- May 8, 2008 -- The increased risk of myocardial infarction (MI) previously seen in patients on rosiglitazone treatment actually ... DG News Diabetes drug Avandia ups risk of heart attack - May 23, 2007 Currently, India, with the world's largest diabetic population, has 10 drug makers selling versions of the same drug, rosiglitazone. Some 10 million people ... Livemint … ups heart risk.(This Week)(rosiglitazone) - Science News |... - Sep 15, 2007 This Week)(rosiglitazone) ... find Science News articles. The popular diabetes drug rosiglitazone, marketed as Avandia, more than doubles the long-term risk ... Pay-Per-View - Science News - HighBeam Research … drug study: patients who take rosiglitazone might consider... - Jul 1, 2007 Diabetes patients concerned about taking rosiglitazone (Avandia) after a recent ... But if patients haven't spoken with their doctors about rosiglitazone, ... Free with registration - Heart Advisor - AccessMyLibrary.com The Perfect Storm -- Drug Safety and Rosiglitazone - Jul 24, 2007 On May 21, 2007, the New England Journal of Medicine published 2 contributions online on the cardiovascular risks of rosiglitazone (Avandia)-- an article by ... Medscape … And Availability Of Avandaryl(TM) (rosiglitazone Maleate And... - Feb 2, 2006 This medication combines rosiglitazone, the most widely prescribed TZD ... Rosiglitazone directly targets insulin resistance, an underlying cause of type 2 ... Medical News Today - Medical News Today (press release) Article: Spironolactone effectively counteracts rosiglitazone... - Sep 1, 2005 Spironolactone effectively counteracts rosiglitazone-associated edema.(Metabolic Disorders) ... find Family Practice News articles. Pay-Per-View - Family Practice News - HighBeam Research Cardiovascular Safety of Low-Dose Rosiglitazone - Jan 14, 2008 In the trial by Hollander et al, 1 the excess rates of cardiovascular (CV) events with rosiglitazone use (2.4% in the 2-mg/d group and 1.4% in the 4-mg/d ... Archives of Internal Medicine DREAM: Rosiglitazone Effective in Preventing Diabetes - Oct 24, 2006 October 24, 2006 (Toronto) — The results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study indicate that ... Medscape Glargine Vs. Rosiglitazone Addition in Poorly Controlled Type 2... - Jan 9, 2007 First study to examine the mechanism(s) by which the addition of rosiglitazone or bedtime glargine insulin improves glucose homeostasis in poorly controlled ... Diabetes In Control Rosiglitazone (Systemic).(Drug overview) - Aug 1, 2006 Rosiglitazone (ROS-e-glit-a-zone) is used to treat a certain type of diabetes mellitus (sugar diabetes) called type 2 diabetes. It may be used alone or with ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com METFORMIN AND ROSIGLITAZONE (Oral route) - met-FOR-min hye-droe … - May 1, 2007 ...* Lactic acidosis is a rare, but serious, metabolic complication that can occur due to metformin accumulation during treatment with rosiglitazone maleate ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com This Time It's A Draw for Rosiglitazone (Avandia) and Pioglitazone... - Sep 28, 2007 By Peggy Peck, Executive Editor, MedPage Today. BURLINGTON, Mass., Sept. 28 -- Pooled data from seven randomized trials of thiazolidinediones for type 2 ... MedPage Today Can Rosiglitazone Prevent Type 2 Diabetes? - Dec 15, 2006 Type 2 diabetes mellitus affects about 5 percent of adults and has rapidly rising prevalence that is a significant concern. Persons with impaired glucose ... AAFP News Now Studies in Europe show Rosiglitazone can slow down diabetes by 32% - Dec 5, 2006 Complications from the disease such as heart failure can be slowed down further and prevented with a particular drug. The downside - it costs 3 to 4 times ... Pay-Per-View - Channel News Asia - Factiva, from Dow Jones Brand Names/Synonyms: Rosiglitazone is also known by the following brand names and/or synonymsAvandia; Rosigliazone Maleate; Rosiglitazone; Rosiglitazone Maleate; Rosiglitazone and Its Intermediates; Rosiglizole Drug Category: Rosiglitazone is categorized under the following by the FDA: Vasodilator Agents; Hypoglycemic Agents; Fibrinolytic Agents; Thazolidinediones; ATC:A10BG02 Dosage Forms: Tablets Absorption: The absolute bioavailability of rosiglitazone is 99%. Peak plasma concentrations are observed about 1 hour after dosing. Administration of rosiglitazone with food resulted in no change in overall exposure (AUC), but there was an approximately 28% decrease in Cmax and a delay in Tmax (1.75 hours). These changes are not likely to be clinically significant; therefore, AVANDIA may be administered with or without food. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 5-[[4-[2-(methyl-pyridin-2-yl-amino)ethoxy]phenyl]methyl]thiazolidine-2,4-dione |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |